Ohio board rejects medical marijuana for autism
Cleveland.com highlights UC expert's testimony to State Medical Board
The State Medical Board of Ohio rejected proposals to add autism and female orgasmic difficulty disorder to the list of qualified conditions for which patients can obtain medical marijuana.
The decision came following testimony from experts including the University of Cincinnati's Craig Erickson, MD, associate professor in UC's College of Medicine and a Cincinnati Children's Hospital physician researcher, who spoke against the inclusion of autism on the approved conditions list.
Cleveland.com highlighted Erickson's and other experts' testimony in an article about the board's decision. Erickson told the board adults and children with autism are increasingly testing positive for THC even though there are not reports of clearly positive change in autism spectrum disorder patients.
Erickson added he's concerned that some patients are not capable of giving consent for cannabis, due to the communication deficits that are part of their autism spectrum disorder.
Read the Cleveland.com article.
Featured photo at top of marijuana leaves. Photo/Jeff W/Unsplash.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.